Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Health Catalyst
HCAT
$168M
| $3.65M | ﹤0.01% |
484,241
-37,121
| -7% | -$339K |
|
2402
OrthoPediatrics
KIDS
$536M
| $3.63M | ﹤0.01% |
124,428
+1,275
| +1% | +$35.7K |
|
2403
SandRidge Energy
SD
$500M
| $3.63M | ﹤0.01% |
248,921
+2,774
| +1% | +$37.5K |
|
|
EB
2404
DELISTED
Eventbrite
EB
| $3.6M | ﹤0.01% |
657,512
+12,048
| +2% | +$87.4K |
|
2405
MetroCity Bankshares
MCBS
$1.03B
| $3.6M | ﹤0.01% |
144,229
+5,480
| +4% | +$131K |
|
|
NVRO
2406
DELISTED
NEVRO CORP.
NVRO
| $3.59M | ﹤0.01% |
248,894
-31,634
| -11% | -$523K |
|
|
GOGL
2407
DELISTED
Golden Ocean Group
GOGL
| $3.59M | ﹤0.01% |
277,111
-874,163
| -76% | -$10M |
|
2408
Liquidity Services
LQDT
$1.19B
| $3.58M | ﹤0.01% |
192,569
+1,911
| +1% | +$33.2K |
|
2409
Tootsie Roll Industries
TR
$2.98B
| $3.57M | ﹤0.01% |
118,379
+7,839
| +7% | +$237K |
|
|
EWCZ
2410
DELISTED
European Wax Center
EWCZ
| $3.57M | ﹤0.01% |
275,234
+3,398
| +1% | +$48.6K |
|
2411
Franklin Covey
FC
$244M
| $3.57M | ﹤0.01% |
90,988
+888
| +1% | +$35.4K |
|
2412
Savers
SVV
$1.65B
| $3.57M | ﹤0.01% |
185,253
+1,563
| +0.9% | +$29.2K |
|
2413
Arhaus
ARHS
$1.17B
| $3.57M | ﹤0.01% |
231,851
+6,515
| +3% | +$83.9K |
|
2414
LendingTree
TREE
$474M
| $3.55M | ﹤0.01% |
83,844
-143,458
| -63% | -$5.02M |
|
2415
RUM Group Inc
RUM
$1.77B
| $3.55M | ﹤0.01% |
439,221
+2,325
| +0.5% | +$15K |
|
2416
ARS Pharmaceuticals
SPRY
$528M
| $3.53M | ﹤0.01% |
345,295
+15,745
| +5% | +$117K |
|
2417
MediaAlpha
MAX
$758M
| $3.53M | ﹤0.01% |
173,178
+1,913
| +1% | +$30.5K |
|
2418
NextDecade
NEXT
$1.74B
| $3.53M | ﹤0.01% |
621,027
+31,516
| +5% | +$157K |
|
|
TELL
2419
DELISTED
Tellurian Inc.
TELL
| $3.52M | ﹤0.01% |
5,319,789
+457,979
| +9% | +$311K |
|
|
CMRC
2420
Commerce.com Inc Series 1
CMRC
$269M
| $3.51M | ﹤0.01% |
509,460
+22,216
| +5% | +$178K |
|
2421
Kodiak Gas Services
KGS
$6.01B
| $3.51M | ﹤0.01% |
128,353
+1,255
| +1% | +$30.3K |
|
2422
U-Haul Holding Co
UHAL
$14.4B
| $3.47M | ﹤0.01% |
51,397
+973
| +2% | +$64.3K |
|
2423
Klaviyo
KVYO
$5.72B
| $3.47M | ﹤0.01% |
136,160
-1,416
| -1% | -$37.8K |
|
2424
Vanguard Information Technology ETF
VGT
$147B
| $3.46M | ﹤0.01% |
52,816
-3,728
| -7% | -$236K |
|
|
RVNC
2425
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.44M | ﹤0.01% |
700,050
+22,686
| +3% | +$134K |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.